1.02
price down icon6.42%   -0.07
after-market Handel nachbörslich: 1.00 -0.02 -1.96%
loading
Schlusskurs vom Vortag:
$1.09
Offen:
$1.06
24-Stunden-Volumen:
820.94K
Relative Volume:
1.18
Marktkapitalisierung:
$101.07M
Einnahmen:
$100.56M
Nettoeinkommen (Verlust:
$-119.05M
KGV:
-0.8293
EPS:
-1.23
Netto-Cashflow:
$-231.16M
1W Leistung:
-20.93%
1M Leistung:
-29.90%
6M Leistung:
-77.92%
1J Leistung:
-82.29%
1-Tages-Spanne:
Value
$1.01
$1.08
1-Wochen-Bereich:
Value
$1.01
$1.278
52-Wochen-Spanne:
Value
$1.01
$6.78

Alector Inc Stock (ALEC) Company Profile

Name
Firmenname
Alector Inc
Name
Telefon
415-231-5660
Name
Adresse
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Name
Mitarbeiter
238
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-05
Name
Neueste SEC-Einreichungen
Name
ALEC's Discussions on Twitter

Vergleichen Sie ALEC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ALEC
Alector Inc
1.02 101.07M 100.56M -119.05M -231.16M -1.23
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Alector Inc Stock (ALEC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-17 Herabstufung Mizuho Outperform → Neutral
2024-12-16 Herabstufung Stifel Buy → Hold
2024-12-04 Herabstufung BofA Securities Neutral → Underperform
2024-11-29 Bestätigt H.C. Wainwright Buy
2024-11-26 Herabstufung Morgan Stanley Equal-Weight → Underweight
2023-12-14 Hochstufung Stifel Hold → Buy
2023-12-12 Eingeleitet Deutsche Bank Buy
2023-09-25 Eingeleitet Goldman Sell
2023-09-22 Eingeleitet Cantor Fitzgerald Overweight
2023-01-06 Herabstufung BofA Securities Buy → Neutral
2022-09-09 Herabstufung Morgan Stanley Overweight → Equal-Weight
2022-07-07 Eingeleitet Mizuho Buy
2022-04-13 Eingeleitet Goldman Sell
2022-03-08 Herabstufung Stifel Buy → Hold
2021-09-27 Eingeleitet William Blair Outperform
2021-01-15 Fortgesetzt BofA Securities Buy
2020-06-24 Eingeleitet H.C. Wainwright Buy
2020-04-28 Eingeleitet Goldman Buy
2020-03-06 Eingeleitet Citigroup Buy
2020-02-27 Eingeleitet Barclays Overweight
2020-02-19 Eingeleitet Stifel Buy
2019-11-21 Eingeleitet BTIG Research Buy
2019-03-04 Eingeleitet Barclays Overweight
2019-03-04 Eingeleitet BofA/Merrill Buy
2019-03-04 Eingeleitet Morgan Stanley Overweight
2019-03-04 Eingeleitet SVB Leerink Outperform
Alle ansehen

Alector Inc Aktie (ALEC) Neueste Nachrichten

pulisher
Apr 03, 2025

Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise - insights.citeline.com

Apr 03, 2025
pulisher
Apr 03, 2025

Frontotemporal Dementia Pipeline 2025: Key Companies, MOA, - openPR.com

Apr 03, 2025
pulisher
Apr 03, 2025

Brokerages Set Alector, Inc. (NASDAQ:ALEC) Price Target at $3.50 - Defense World

Apr 03, 2025
pulisher
Mar 31, 2025

Alector stock hits 52-week low at $1.24 amid market challenges - Investing.com

Mar 31, 2025
pulisher
Mar 30, 2025

Charles Schwab Investment Management Inc. Reduces Stock Position in Alector, Inc. (NASDAQ:ALEC) - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Alector, Inc. (NASDAQ:ALEC) Shares Sold by Charles Schwab Investment Management Inc. - The AM Reporter

Mar 30, 2025
pulisher
Mar 28, 2025

Alector Announces Resignation of Chief Medical Officer - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Alector Appoints New Chief Medical Officer - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Alector Provides Executive Leadership Update - The Manila Times

Mar 28, 2025
pulisher
Mar 28, 2025

Alector Names Neurology Expert as CMO Amid Crucial Phase 3 Dementia Trial - Stock Titan

Mar 28, 2025
pulisher
Mar 25, 2025

Alector Cuts Staff Again, This Time Laying Off 13% of Workforce - BioSpace

Mar 25, 2025
pulisher
Mar 21, 2025

Alector, Inc. (NASDAQ:ALEC) Not Doing Enough For Some Investors As Its Shares Slump 26% - simplywall.st

Mar 21, 2025
pulisher
Mar 19, 2025

Alector stock hits 52-week low at $1.29 amid sharp annual decline - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments - Investing.com

Mar 18, 2025
pulisher
Mar 13, 2025

Alector: Q4 Of 2025 FTD-GRN Treatment Data Is Important Inflection Point (NASDAQ:ALEC) - Seeking Alpha

Mar 13, 2025
pulisher
Mar 12, 2025

Mizuho’s latest rating for ALEC stock - Knox Daily

Mar 12, 2025
pulisher
Mar 11, 2025

Alector at Leerink Global Healthcare Conference: Strategic Advances in Neurodegeneration - Investing.com India

Mar 11, 2025
pulisher
Mar 10, 2025

Alector announces workforce reduction to cut costs By Investing.com - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Alector announces workforce reduction to cut costs - Investing.com

Mar 10, 2025
pulisher
Mar 10, 2025

Alector to Cut 13% of Workforce - MarketWatch

Mar 10, 2025
pulisher
Mar 10, 2025

Have Alector Insiders Been Selling Stock? - simplywall.st

Mar 10, 2025
pulisher
Mar 09, 2025

Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Consensus Target Price from Analysts - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

Alector assumed with an Underweight at Morgan Stanley - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies By Investing.com - Investing.com UK

Mar 06, 2025
pulisher
Mar 05, 2025

Alector Executives Sell Shares to Satisfy Tax Obligations - TradingView

Mar 05, 2025
pulisher
Mar 04, 2025

Alector stock hits 52-week low at $1.54 amid sharp annual decline - Investing.com Australia

Mar 04, 2025
pulisher
Mar 04, 2025

William Blair Predicts Alector’s Q1 Earnings (NASDAQ:ALEC) - The AM Reporter

Mar 04, 2025
pulisher
Mar 03, 2025

Alector stock hits 52-week low at $1.54 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 02, 2025

Research Analysts Set Expectations for Alector Q1 Earnings - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Earnings Update: Alector, Inc. (NASDAQ:ALEC) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St

Mar 01, 2025
pulisher
Feb 28, 2025

Alector (NASDAQ:ALEC) Receives "Buy" Rating from HC Wainwright - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Alector Full Year 2024 Earnings: Beats Expectations - Yahoo Finance

Feb 28, 2025
pulisher
Feb 27, 2025

Alector’s Earnings Call: Progress Amid Challenges - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Alector (NASDAQ:ALEC) Releases Earnings Results, Beats Expectations By $0.59 EPS - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Alector Inc (ALEC) Shares Up Despite Recent Market Volatility - The News Heater

Feb 27, 2025
pulisher
Feb 27, 2025

Alector, Inc. (NASDAQ:ALEC) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Alector Inc Q4 2024 sees cautious market reaction By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

Alector Inc (ALEC) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising Clinical Advances - GuruFocus.com

Feb 27, 2025
pulisher
Feb 27, 2025

Alector: Q4 Earnings Snapshot - mySA

Feb 27, 2025
pulisher
Feb 27, 2025

The Bold Bet on Brain Health: Alector’s Race Against Time in Neurodegenerative Research - Smartphone Magazine

Feb 27, 2025
pulisher
Feb 27, 2025

Alector Inc (NASDAQ:ALEC): The Biotech Pioneering New Frontiers in Neurodegenerative Diseases - Jomfruland.net

Feb 27, 2025
pulisher
Feb 27, 2025

Alector beats Q4 estimates, shares edge higher By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

Alector Inc (ALEC) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising ... - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

Alector, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 27, 2025

Finanzdaten der Alector Inc-Aktie (ALEC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):